Advanced Malignant Neoplasm Recruiting Phase 1 Trials for Dinaciclib (DB12021)

IndicationStatusPhase
DBCOND0033490 (Advanced Malignant Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01434316Veliparib and Dinaciclib in Treating Patients With Advanced Solid TumorsTreatment